Cutaneous drug reactions;Toxidermies médicamenteuses: Quelques nouveautés

Revue Francaise d'Allergologie et d'Immunologie Clinique

Volumn 42, Issue 1, 2002, Pages 71-74

  Roujeau, J C ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Drug eruptions; Drug hypersensitivity; Eosinophils; T lymphocytes

Indexed keywords

ANGIOTENSIN II ANTAGONIST; ANTIRETROVIRUS AGENT; CYCLOOXYGENASE 2 INHIBITOR; KETOPROFEN; TERBINAFINE;

ALLERGY; CONFERENCE PAPER; DRUG DOSE; DRUG ERUPTION; DRUG HYPERSENSITIVITY; EOSINOPHIL; IMMUNE RESPONSE; T LYMPHOCYTE;

EID: 0036151541     PISSN: 03357457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0335-7457(01)00116-2     Document Type: Conference Paper

References (16)

1. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS)
2. Benefit-risk assessment of acne therapies
3. Clinical perspectives on HIV-associated lipodystrophy syndrome: An update
4. Terbinafine therapy may be associated with the development of psoriasis de novo or its exacerbation: Four case reports and a review of drug-induced psoriasis
5. Angioneurotic edema attributed to the use of losartan
6. Prolonged photosensitivity following contact photoallergy to ketoprofen
7. Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity
8. Prospective evaluation of detoxification pathways as markers of cutaneous adverse reactions to sulphonamides in AIDS
9. Recognition of sulfomethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals
10. Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions
11. Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome
12. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
13. Prospective evaluation of risk factors of cutaneous drug reactions to sulfonamides in AIDS patients
14. Toxic epidermal necrolysis and Stevens-Johnson syndrome: Does early withdrawal of causative drugs decrease the risk of death?
15. Black reduced toxicity with gradual initiation of trimethoprimsulfamethoxazole as primary prophylaxis for Pneumocystis carinii pneumonia
16. Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids